期刊文献+

头颈恶性肿瘤基因治疗的回顾与展望 被引量:1

Review and prospect of gene therapy for head and neck cancers
原文传递
导出
作者 韩德民
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第34期2377-2379,共3页 National Medical Journal of China
  • 相关文献

参考文献9

  • 1Cavazzana-Calvo M, Thrasher A, Mavilio F. The future of gene therapy. Nature, 2004, 427: 779-781.
  • 2Adams A,Frank DK. Gene therapy for head and neck cancer. Surg Oncol Clin N Am,2002, 11:589-606.
  • 3张珊文,肖绍文,刘长清,孙艳,苏星,李东明,徐刚,蔡勇,朱广迎,徐博,吕有勇.重组人p53腺病毒注射液联合放射线治疗头颈鳞癌的Ⅱ期临床试验[J].中华医学杂志,2003,83(23):2023-2028. 被引量:69
  • 4韩德民,黄志刚,张伟,于振坤,王琪,倪鑫,陈晓红,潘锦华,王鸿.重组人p53腺病毒注射液治疗喉癌的Ⅰ期临床试验及追踪观察[J].中华医学杂志,2003,83(23):2029-2032. 被引量:60
  • 5陈传本,潘建基,徐鹭英.重组人p53腺病毒注射液结合放射治疗鼻咽癌Ⅱ期临床试验观察[J].中华医学杂志,2003,83(23):2033-2035. 被引量:52
  • 6Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol, 2003, 21:117-122.
  • 7Qiu ZH, Wu CT, Lao MF, et al. Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes. Cancer Lett, 2002, 182:147-154.
  • 8Bauerschmitz GJ, Barker SD, Hemminki A. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review). Int J Oncol, 2002, 21:1161-1174.
  • 9张晓志 张卫民 余清.重组人p53腺病毒制品治疗肿瘤研究进展[J].癌症进展杂志,2004,2(1):56-63.

二级参考文献32

  • 1孙学华.喉癌治疗失败的原因分析[J].肿瘤防治研究,1994,21(5):317-318. 被引量:1
  • 2甘晓凡,周玉霞,蔡丽萍,刘明霞.中青年喉癌的疗效分析[J].中华耳鼻咽喉科杂志,1996,31(4):201-202. 被引量:1
  • 3Yumi Knegae, Miho Makimura and Izumu Satio. A simple and efficient method for purifica-tion of infections recombinant adenovirus. Jpn J Med Sci Biol, 1994,47:157-166.
  • 4Brand K, Klocke R, Pobetaling A, et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther, 1999, 6: 1054-1063.
  • 5Li JH, Lax SA,Kim J, et al. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys,1999, 3:607-616.
  • 6Clayman GL,el-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol, 1998, 6: 2221-2232.
  • 7Gary L, Clayman, Douglas K, et al. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head nad neck cancer. Clin Cancer Res, 1999, 5: 1715-1722.
  • 8Lianglin Zhang, Dihua Yu, Mei Hu, et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res, 2000,60:3655-3661.
  • 9Zhang EP, Lian PG, Cai KL,et al. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1 302 patients. Int J Radiat Oncol Biol Phys, 1989,16: 301-305.
  • 10Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5307 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys, 1992,20:261-270.

共引文献126

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部